MSH|^~\&|MIC|ARH|||202003131500||ORU^R01|4185837|D|2.3|||AL|NE
PID|1||AB00008388|AB8306|LABTEST^UCI^ROSE||19851010|F||||||||||AB000737/19|9874794993
OBR|1|40408^MIC|00030465^20:U0000043R^MIC^20:U43^40408|500.1000^U^Urine Culture^^^630-4||202003131032|202003131000|||||||202003131032|Urine^^^Midstream urine|||||||||MB|D||||
OBX|1|CE|500.1000^U^Urine Culture^^^630-4^O:KPNE|1.1|KPNE^Klebsiella pneumoniae||||||D|||202003131033
OBX|2|ST|500.1000^U^Urine Culture^^^630-4^P:COLCOUNT10|1.1|||||||D|||202003131033
OBX|3|ST|500.1000^U^Urine Culture^^^630-4^R:1000|1.1|>100|x 10*6 CFU/L||A|||D|||202003131033
OBR|2||00030465^20:U0000043R^MIC^20:U43^40408|903.3150^N391^Vitek N391 Sensitivity^^^29576-6||202003131032|202003131000|||||||202003131032|Urine^^^Midstream urine|||||||||MB|D|U^1.1|||40408^MIC
OBX|1|ST|100.900^CFM^Cefixime^^80-2^80-2|||||S|||D|||202003131033
OBX|2|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||I|||D|||202003131033
OBX|3|ST|101.100^CF^Cephalexin^^149-5^149-5|||||I|||D|||202003131033
OBX|4|ST|200.100^AM^Ampicillin^^28-1^28-1|||||R|||D|||202003131033
OBX|5|ST|300.200^GM^Gentamicin^^267-5^267-5|||||S|||D|||202003131033
OBX|6|ST|500.650^CP^Ciprofloxacin^^185-9^185-9|||||S|||D|||202003131033
OBX|7|ST|500.700^FD^Nitrofurantoin^^363-2^363-2|||||S|||D|||202003131033
OBX|8|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||D|||202003131033
OBX|9|ST|700.000^TE^Tetracycline^^496-0^496-0|||||S|||D|||202003131033

MSH|^~\&|LAB|ARH|||202003131500||ORU^R01|4185840|D|2.3|||AL|NE
PID|1||AB00008388|AB8306|LABTEST^UCI^ROSE||19851010|F||||||||||AB000737/19|9874794993
OBR|1|40324^LAB|00030418^1203:C00002R^LAB^120320:C2^40324|500.1500^CP4^Chem 4 - Lytes^^^24326-1||202003121345|202003121348|||||||202003121348||||||||||LAB|D||||
OBX|1|ST|500.1900^NA^Sodium^^2951-2^2951-2|1|120^^Y|mmol/L|135-145|L||A^S|D|||202003121355
OBX|2|ST|500.2000^K^Potassium^^2823-3^2823-3|1|2.0^^Y|mmol/L|3.5-5.0|LL||A^S|D|||202003121355
NTE|1||*CRITICAL VALUE
OBX|3|ST|500.2100^CL^Chloride^^2075-0^2075-0|1|98^^Y|mmol/L|98-108|N||A^S|D|||202003121355
OBX|4|ST|500.2200^BICARB^Bicarbonate^^1962-0^1962-0|1|30^^Y|mmol/L|20-30|N||A^S|D|||202003121355
OBX|5|ST|500.2300^GAP^Anion Gap^^33037-3^33037-3|1|0^^Y|mmol/L|3-16|L||A^S|D|||202003121355
OBR|2|40324^LAB|00030418^1203:C00002R^LAB^120320:C2^40324|500.3900^MG^Magnesium^^2601-3^2601-3||202003121345|202003121348|||||||202003121348||||||||||LAB|D||||
OBX|1|ST|500.3900^MG^Magnesium^^2601-3^2601-3|1|0.5^^Y|mmol/L|0.7-1.2|L||A^S|D|||202003121355
NTE|1||This is a test short message.
NTE|2||In management of Eclampsia, the reference range is not
NTE|3||transferable as a therapeutic range.
OBR|3|40324^LAB|00030418^1203:C00002R^LAB^120320:C2^40324|520.4200^IRON^Iron Studies Profile^^^50190-8||202003121345|202003121348|||||||202003121348||||||||||LAB|D||||
OBX|1|ST|520.4300^FE^Iron^^14798-3^14798-3|1|9^^Y|umol/L|9-30|N||A^S|D|||202003121355
OBX|2|ST|520.4500^TIBC^Total Iron Binding Capacity^^14800-7^14800-7|1|50^^Y|umol/L|45-70|N||A^S|D|||202003121355
OBX|3|ST|520.4600^TRFSAT^Transferrin Saturation^^6796-7^14801-5|1|0.18^^Y||0.15-0.55|N||A^S|D|||202003121355

MSH|^~\&|LAB|ARH|||202003131500||ORU^R01|4185841|D|2.3|||AL|NE
PID|1||AB00008388|AB8306|LABTEST^UCI^ROSE||19851010|F||||||||||AB000737/19|9874794993
OBR|1|40325^LAB|00030418^1203:CS00003R^LAB^120320:CS3^40325|523.1895^HIV^HIV -Nominal Reporting^^^75666-8||202003121345|202003121348|||||||202003121348||||||||||LAB|D||||
OBX|1|ST|523.19061^HIV EIA4G^HIV 1 and 2 Ab/Ag EIA Screen^HIVCC^XXX-2887^XXX-2887|1|Negative^^N|||N||A^S|D|||202003121428